Beyond Air Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Good morning, everyone. Suraj Kalia, Senior Medical Device Analyst at Oppenheimer. The third day of the Oppenheimer Annual Healthcare Conference. We're pleased to have Beyond Air present this morning. From Beyond Air, we have Steve Lisi, CEO. Steve, I'll let you take the floor. I'll resurface about three to five minutes toward the end for Q&A.
Great. Thanks, Suraj. Thanks for having us, much appreciated. So I'm going to talk about Beyond Air, the company. Here's our disclaimers. You can read them at your leisure.
Again, back to our mission of nitric oxide. Today, nitric oxide is approved and used in the hospital setting, restricted to the ICU only. We'll be taking it to all corners of the hospital and eventually into the patient's homes where they can self-administer nitric oxide.
These are our systems. So you can see in the middle here, we have our LungFit PH, which is FDA approved. This is FDA approved for persistent
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |